Evidence map›Paper›PMID 37754082›Full record

ReviewBiosensors2023

Molybdenum Disulfide as Tunable Electrochemical and Optical Biosensing Platforms for Cancer Biomarker Detection: A Review.

Ziyue Qin, Jiawei Zhang, Shuang Li

Abstract readReview
In one paragraph

Review in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Advances in MoSBiosensors · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ziyue QinMedical College, Tianjin University, Tianjin 300072, China.
Jiawei ZhangMedical College, Tianjin University, Tianjin 300072, China.
Shuang LiMedical College, Tianjin University, Tianjin 300072, China.ORCID 0000-0002-3483-5087

Funding

HongKong Scholars Program XJ2021034National Key Research and Development Program of China 2022YFF1202700National Natural Science Foundation of China 82001922
6 · The paper itself

Abstract

Cancer is a common illness with a high mortality. Compared with traditional technologies, biomarker detection, with its low cost and simple operation, has a higher sensitivity and faster speed in the early screening and prognosis of cancer. Therefore, extensive research has focused on the development of biosensors and the construction of sensing interfaces. Molybdenum disulfide (MoS

Indexed as

Biomarkers, TumorNeoplasmsCatalysisDisulfidesElectronicsMolybdenumBiomarkers, TumorDisulfidesMolybdenummolybdenum disulfidecancer biomarkersdetectionelectrochemical sensormolybdenum disulfideoptical sensor

Identifiers

PMID37754082
PMCPMC10527254

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.